浅析呼吸道感染继发急性中耳炎的临床治疗方式

Analysis of Clinical Treatment Methods for Acute Otitis Media Secondary to Respiratory Tract Infection

本研究的目的是探讨急性上呼吸道感染继发急性中耳炎患儿临床治疗分析。将哈尔滨市双城区人民医院98例急性上呼吸道感染继发急性中耳炎患儿分为两组,对比两组疗效及临床症状改善情况。结果显示观察组总有效率显著高于对照组(92.82%vs81.04%);观察组病原菌转阴率(88.56%)、鼓室压有效降低率(95.13%)显著高于对照组;观察组不良反应发生率与对照组对比(7.04%vs15.87%)。因此,观察组采用布地奈德混悬液雾化吸入治疗在急性上呼吸道感染继发急性中耳炎患儿临床治疗中具有显著的优势,能够提高疗效,改善临床症状,降低病原菌转阴率和鼓室压,促进听力的改善,缩短起效时间和住院时间,且不良反应发生率较低。

The purpose of this study is to explore the clinical treatment analysis of children with acute upper respiratory tract infection secondary to acute otitis media.98 children with acute upper respiratory tract infection secondary acute otitis media in Shuangcheng District People's Hospital of Harbin City were divided into two groups,and the efficacy and clinical symptom improvement of the two groups were compared.The results showed that the total effective rate of the observation group was significantly higher than that of the control group(92.82%vs 81.04%);The observation group had a significantly higher conversion rate of pathogenic bacteria to negative(88.56%)and an effective reduction rate of tym-panic pressure(95.13%)compared to the control group;The incidence of adverse reactions in the observation group was compared with that in the control group(7.04%vs 15.87%).Therefore,the observation group using budesonide suspen-sion nebulized inhalation therapy has significant advantages in the clinical treatment of children with acute upper respi-ratory tract infection secondary acute otitis media.It can improve the therapeutic effect,improve clinical symptoms,reduce the conversion rate of pathogens to negative and tympanic pressure,promote hearing improvement,shorten the onset time and hospitalization time,and have a lower incidence of adverse reactions.